We aimed to establish a method to determine whether microRNA-193b (miR-193b) levels in ABCA1-labeled serum exosomes might serve as a marker for the diagnosis of Alzheimer's disease. This evidence concerns the gene ABCA1 and early-onset autosomal dominant Alzheimer disease.